Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation

British Journal of Haematology

Volumn 156, Issue 5, 2012, Pages 683-686

  Fenk, Roland ^a   Neubauer, Florian ^a   Bruns, Ingmar ^a   Schröder, Thomas ^a   Germing, Ulrich ^a   Haas, Rainer ^a   Kobbe, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Autologous transplantation; Multiple myeloma; Secondary primary malignancy

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; INTERFERON; LENALIDOMIDE; MELPHALAN; THALIDOMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CAUSE OF DEATH; DRUG EXPOSURE; DRUG MEGADOSE; EYEBROW; EYEBROW SQUAMOUS CELL CARCINOMA; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH DOSE CHEMOTHERAPY; HODGKIN DISEASE; HUMAN; INDUCTION CHEMOTHERAPY; LETTER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PANCREAS CANCER; PAROTID GLAND CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RETROSPECTIVE STUDY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES;

EID: 84857033915     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08905.x     Document Type: Letter

References (10)

1. Attal, M., Lauwers, V.C., Marit, G., Caillot, D., Facon, T., Hulin, C., Moreau, P., Mathiot, C., Roussel, M., Payen, C., Avet-Loiseau, H. & Harousseau, J.L. (2010) Maintenance treatment with lenalidomide after transplantation for MYELOMA: final analysis of the IFM 2005-02. Blood (ASH Annual Meeting Abstracts), 116, 310.
2. Barlogie, B., Attal, M., Crowley, J., van Rhee, F., Szymonifka, J., Moreau, P., Durie, B.G. & Harousseau, J.L. (2010) Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences. Journal of Clinical Oncology, 28, 1209-1214.
3. Bergsagel, D.E., Bailey, A.J., Langley, G.R., MacDonald, R.N., White, D.F. & Miller, A.B. (1979) The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. New England Journal of Medicine, 301, 743-748.
4. Cuzick, J., Erskine, S., Edelman, D. & Galton, D.A. (1987) A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults. British Journal of Cancer, 55, 523-529.
5. Dong, C. & Hemminki, K. (2001) Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. British Journal of Cancer, 85, 997-1005.
6. Dores, G. (2006) New Malignancies Among Cancer Survivors. SEER Cancer Registries (1973-2000) Chapter 16. National Cancer Institutes, Bethesda, MD, USA.
7. Hasskarl, J., Ihorst, G., De, P.D., Schrottner, P., Zerweck, A., Wasch, R. & Engelhardt, M. (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leukaemia & Lymphoma, 52, 247-259.
8. Kumar, S.K., Rajkumar, S.V., Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Buadi, F.K., Zeldenrust, S.R., Dingli, D., Russell, S.J., Lust, J.A., Greipp, P.R., Kyle, R.A. & Gertz, M.A. (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood, 111, 2516-2520.
9. McCarthy, P.L., Owzar, K., Anderson, K.C., Hofmeister, C.C., Hurd, D.D., Hassoun, H., Giralt, S., Stadtmauer, E.A., Richardson, P.G., Weisdorf, D.J., Vij, R., Moreb, J.S., Callander, N.S., Van Besien, K., Gentile, T., Isola, L., Maziarz, R.T., Gabriel, D.A., Bashey, A., Landau, H., Martin, T., Qazilbash, M.H., Levitan, D., McClune, B. & Hars, V. (2010) Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104. Blood (ASH Annual Meeting Abstracts), 116, 37.
10. Palumbo, A., Gay, F., Falco, P., Crippa, C., Montefusco, V., Patriarca, F., Rossini, F., Caltagirone, S., Benevolo, G., Pescosta, N., Guglielmelli, T., Bringhen, S., Offidani, M., Giuliani, N., Petrucci, M.T., Musto, P., Liberati, A.M., Rossi, G., Corradini, P. & Boccadoro, M. (2010) Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients. Journal of Clinical Oncology, 28, 800-807.